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Abstract
Background: As anorexia and hypermetabolism are common in cirrhosis, leptin levels may be
increased in this disease. In this study, we investigated the relation between the severity of disease
and serum leptin levels in post-hepatitis cirrhosis and the role of body composition, gender and
viral aetiology of cirrhosis in this association.
Methods: Thirty-five cases with post-hepatitis cirrhosis and 15 healthy controls were enrolled in
this study. Body composition including body mass index, body fat percentage and body fat mass
were determined. Serum leptin levels were assayed.
Results:  Leptin levels were significantly higher among cirrhotic patients independent of sex
compared to controls (p = 0.001). Female patients in both groups have had higher leptin levels than
males (in cirrhotics p = 0.029, in controls p = 0.02).
Cirrhotic patients in each of A, B and C subgroups according to the Child- Pugh classification
revealed significantly different levels compared to controls (p = 0.046, p = 0.004, p = 0.0001,
respectively). Male cirrhotics in Child-Pugh Class B and C subgroups had significantly higher leptin
levels compared to male controls (p = 0.006, p = 0.008). On the other hand, female patients only
in Child Pugh class C subgroup have had higher levels of serum leptin compared to controls (p =
0.022).
Child-Pugh classification has been found to be the sole discriminator in determination of leptin
levels in cirrhotics by linear regression (beta: 0.435 p = 0.015).
Conclusion: Serum leptin levels increase in advanced liver disease independently of gender, body
composition in posthepatitic cirrhosis. The increase is more abundant among patients that belong
to C subgroup according to the Child- Pugh classification.
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Background
Leptin, a 16-kilodalton protein, is involved in the regula-
tion of food intake and body composition [1]. It was dis-
covered in 1994 by Friedman et al. [2] and has been
proposed to physiologically regulate body weight by sup-
pressing appetite and increasing energy expenditure
[1,3,4].
In normal humans, circulating level of leptin is higher in
women than in men [3,5]. Besides of gender dependency,
circulating leptin levels correlate with the body fat mass
(BFM) and body mass index (BMI) in healthy subjects [5-
7].
Malnutrition is a common feature of cirrhotic patients [8].
A negative energy balance, and thus catabolism caused by
energy expenditure is considered to be of pathophysiolog-
ical relevance in cirrhosis [9]. Several studies have shown
that circulating leptin levels are modestly elevated in
patients with alcoholic cirrhosis, suggesting that leptin
might be involved in the malnutrition of cirrhosis
[10,11]. While some studies have been supported these
findings, others have reported low serum leptin levels in
post-hepatitis cirrhotic patients [10,12,13]. In addition,
nutritional status of cirrhotic cases represents a wide range
in normal to severe malnutrition, connected with severity
of the disease [8]. It appears that relationship of serum
leptin levels and nutritional status in post-hepatitis cir-
rhosis has not been fully clarified yet.
In this study, we investigated the relation between the
severity of disease and serum leptin levels in post-hepati-
tis cirrhosis and the role of body composition, gender and
viral aetiology of cirrhosis in this association.
Methods
Thirty-five cases with post-hepatitis cirrhosis (17 male, 18
female; mean age: 51.5 ± 12) which were diagnosed on
the basis of the clinical, laboratory, radiological, and/or
histopathological findings, and 15 healthy controls (8
male, 7 female; mean age: 49.4 ± 8) were enrolled in this
study. Cirrhotic cases were assigned into 3 groups on the
basis of the Child-Pugh classification [14] as follows:
Child A (n = 10), Child B (n = 14) and Child C (n = 11).
Causative agents of cirrhosis were viral hepatitis B (n = 20)
and hepatitis C (n = 15). As leptin is a gender dependent
peptide, control and cirrhotic group were divided into two
groups as male and female. Exclusion criteria were history
of cancer, diabetes mellitus, and alcoholism, existence of
pleural effusion, gastrointestinal bleeding, acute infection
and renal failure, treatment with corticosteroids, immu-
nosuppressive agents and oral contraceptive within the
last 6 months.
Control group consisted of healthy individuals with nor-
mal medical history, physical examination and blood bio-
chemistry. None of them have had a restriction of diet for
loosing weight during the last three months. Subjects who
receive any medication have not been included into con-
trol group. The local human institutional review commit-
tee approved the study and written consents were received
from all participants.
Body composition such as BMI, skin fold thickness, body
fat percentage (BFP), and BFM analysis was performed in
both cirrhotic cases and controls. To avoid incorrect BMI
determination and body composition analysis, cirrhotic
cases with ascite and edema had been put on sodium
restricted diet of 51 mmol per day and they were received
diuretics (spiranolactone 100–200 mg and, if necessary,
furosemide 40–80 mg per day) until ascite and edema
have been resolved. Cirrhotic cases with refractory ascite
unresponsive to therapy impaired renal function follow-
ing diuretic therapy, and triceps skinfold thickness less
than 10th percentile [15] were excluded.
BMI was determined as the actual body weight relative to
the square of the body height (BMI, kg/m2). Measure-
ments of skin fold thickness were conducted at four differ-
ent sites on the left side of the body (triceps, biceps, sub-
scapular and supra-iliac) using a Holtain skinfold caliper
(Holtain, Crosswell, Crymych, Dyfed, UK). All the meas-
urements were made by the same physician (FB). Two
measurements were made at each site and the average val-
ues were obtained. The BFP was calculated using the Jack-
sons' formula [16]. BFM was calculated using BFP and
body weight as kilogram.
Diet containing 1 g/kg body weight of protein and 30
kcal/kg body weight of non-protein calories, was
described to be consumed by both cirrhotic and controls
for 2 weeks before serum leptin level measurement was
performed.
Blood samples were obtained in the morning following
12 hours of fasting, they were centrifugated and serum
was separated after storage for one hour at room temper-
ature. Biochemical analyses were done during the same
day. Serum samples for measurement of leptin levels were
stored at -20°C until they were used.
Serum leptin levels were measured as ng/ml via immuno-
radiometric assay (IRMA) method by using Human Lep-
tin IRMA DSL-23100 (Diagnostic Systems Laboratories,
Inc. Texas, USA) kit. Following test procedures, test tubes
were assessed with Gammabyt-CR gamma counter for one
hour. Measurements for standards, controls and serums
were repeated for confirmation. Sensitivity of the test was
0.10 ng/ml.BMC Gastroenterology 2004, 4:23 http://www.biomedcentral.com/1471-230X/4/23
Page 3 of 6
(page number not for citation purposes)
Statistical analysis
Data were presented as median and range. Qualitative var-
iables were assessed by Chi-square test. Between whole
and sub-group comparisons were performed by non-par-
ametric Kruskal-Wallis and Mann-Whitney U tests. A lin-
ear logistic regression analysis was performed with serum
leptin levels as dependent variable and age, gender, BFM,
aetiology of cirrhosis, Child-Pugh classification as inde-
pendent variables in cirrhotics. A p value of <0.05 was
considered statistically significant.
Results
Patient profiles and body composition
Clinical and demographic characteristics of all and gen-
der-based sub-groups were shown in table 1. In male and
female subjects, no statistically significant difference was
observed in age, BMI, BFP and BFM between the controls
and cirrhotic group (both, p > 0.05). Following Child
Pugh Classification, gender based or not, there were no
significant differences in terms of BMI, BFP and BFM
between controls and cirrhotic patients in each group
according to the Child-Pugh classification (Figure 1) for
each sex (Figure 2 and 3).
Leptin levels
Serum leptin levels were significantly higher in cirrhotic
group than controls (p = 0.001) (Table 1). There was a sig-
nificant difference between the leptin levels of men and
women in both control and cirrhotic groups (p = 0.029, p
= 0.02, respectively) (Table 1). Leptin levels were elevated
in both female and male cirrhotics compared to controls
(p = 0.025, p = 0.002, respectively) (Table 1).
Following Child Pugh Classification, there were no significant  differences in terms of body mass index (BMI), body fat per- centage (BFP) and body fat mass (BFM) between controls and  cirrhotic patients (both, p > 0.05) Figure 1
Following Child Pugh Classification, there were no significant 
differences in terms of body mass index (BMI), body fat per-
centage (BFP) and body fat mass (BtFM) between controls 
and cirrhotic patients (both, p > 0.05).
Following Child-Pugh Classification, there were no significant  differences in terms of body mass index (BMI), body fat per- centage (BFP) and body fat mass (BFM) between female con- trols and female cirrhotic patients (both, p > 0.05) Figure 2
Following Child-Pugh Classification, there were no significant 
differences in terms of body mass index (BMI), body fat per-
centage (BFP) and body fat mass (BFM) between female con-
trols and female cirrhotic patients (both, p > 0.05).
Following Child-Pugh Classification, there were no significant  differences in terms of body mass index (BMI), body fat per- centage (BFP) and body fat mass (BFM) between male con- trols and male cirrhotic patients (both, p > 0.05) Figure 3
Following Child-Pugh Classification, there were no significant 
differences in terms of body mass index (BMI), body fat per-
centage (BFP) and body fat mass (BFM) between male con-
trols and male cirrhotic patients (both, p > 0.05).BMC Gastroenterology 2004, 4:23 http://www.biomedcentral.com/1471-230X/4/23
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Cirrhotic patients in each of A, B and C subgroups accord-
ing to the Child- Pugh classification revealed significantly
different leptin levels [(ng/ml with median and range;
9.46 (1.6–30), 12.8 (4.2–18.8), 14.7 (8–41), respec-
tively)] compared to controls (ng/ml with median and
range; 6.4 (0.14–16.3) (p = 0.046, p = 0.004, p = 0.0001,
respectively).
Gender based serum leptin levels of controls and cirrhotic
cases that were grouped according to Child Pugh Classifi-
cation were as shown in Figure 4. Male patients in the con-
trol group had significantly lower serum leptin levels
compared to cirrhotic male cases that belongs to B and C
classes (p = 0.006, p = 0.008, respectively). However, the
difference was not significant between the control males
and Child Pugh class A males (p = 0.234). On the other
hand, female gender revealed significant difference only
between Child Pugh C class patients and controls (p =
0.022).
When age, gender, BFM, hepatitis B and C virus as etio-
logic factors of cirrhosis and child A, B and C as Child-
Pugh classification were tested as independent variables
for determination of serum leptin levels as dependent var-
iable by linear logistic regression analysis in cirrhotic
group, analysis result showed that Child-Pugh classifica-
tion was the sole discriminator in determination of serum
leptin levels in cirrhotic cases (beta: 0.435, p = 0.015)
(Table 2).
Discussion
Leptin regulates body weight by suppressing appetite and
increasing energy expenditure [1,3,4]. Anorexia and
increased energy expenditure usually accompanies to the
cirrhosis [17]. McCullough et al. reported modestly ele-
vated circulating leptin levels in patients with alcoholic
cirrhosis and they suggested that elevated serum leptin
levels in cirrhosis might be responsible for the high prev-
alence of malnutrition among cirrhotic patients [11]. In
our study, we also observed that circulating leptin levels
were increased in non-alcoholic cirrhosis caused by viral
hepatitis without severe energy malnutrition state.
Leptin levels are higher in woman than in men [3,6].
McCullough et al. found higher leptin levels among
female cirrhotics than male cirrhotics, although the differ-
ence was not statistically significant [11]. These concepts
are especially important in cirrhosis, because cirrhotics
have gender-dependent alterations in body composition
and sex steroids [18,19]. When we considered gender in
our study, serum leptin levels were significantly higher
among females than males in both controls and cirrhot-
ics. In addition, cirrhotic females and males had higher
levels of serum leptin than the controls with the same
gender.
Since BMI and BFM values do not differ according to the
sex and the presence or absence of cirrhosis, increased
serum leptin levels could not be simply dedicated to BFM
or malnutrition status in cirrhosis. In addition, linear
regression test in the present study has shown that disease
severity, which was determined by Child-Pugh classifica-
tion, was the sole significant determinant of serum leptin
levels in cirrhosis. In previous studies, association
between the severity of cirrhosis and serum leptin levels is
controversial [11-13]. Henriksen et al suggested that the
elevated circulating leptin in patients with alcoholic cir-
rhosis was most likely caused by a combination of
decreased renal extraction and increased release from sub-
cutaneous abdominal, femoral, gluteal, retroperitoneal,
pelvic, and upper limb fat tissue areas [20]. For this rea-
son, we excluded cases with renal clearance impairment to
avoid of accumulation of leptin in serum. In addition,
using 4 different site of skinfold thickness measurement
to calculate BFP and excluding cases with ascite that do
not respond to diuretic therapy, we targeted to determine
the relationship between body composition and serum
leptin levels in controls and cirrhotics. In this study, BFM
Table 1: Characteristics of cirrhotic patients and controls in whole and gender based sub-groups.
Age Year BMI Kg/m2 BFP % BFM Kg Leptin ng/ml
Cirrhotic (n = 35) 53 (28–73) 24 (18–33) 27.9 (18.5–39) 19.4 (9.6–34) 13.5 (1.6–41)*
Female (n = 18) 48 (28–73) 24 (18–33) 32 (24–39) 20.1 (9.6–34) 15.5 (7.4–41)**
Male (n = 17) 54 (35–66) 23 (19–27) 24.6 (18.5–28) 18.6 (11–26) 10.9 (1.6–36)***
Control (n = 15) 47 (37–65) 24 (20–26) 27.7 (22.4–37) 19.4 (14–26) 6.4 (0.14–16.3)
Female (n = 7) 43 (37–61) 24 (22–25) 33.2 (30–37) 20 (18–26) 7.2 (5.58–16.3)
Male (n = 8) 53 (42–65) 24 (20–26) 24.9 (22.4–28) 18.6 (14–21) 3.7 (0.14–8.7)
Note: Data were presented as median and range.
Groups and subgroups did not differ in terms of age, BMI, BFP, and BFM (p > 0.05).
*Cirrhotic vs. controls (p = 0.001), ** cirrhotic females vs. control females (p = 0.025), ***Cirrhotic males vs. control males (p = 0.002)
BMI; Body mass index, BFP; Body fat percentage, BFM; Body fat massBMC Gastroenterology 2004, 4:23 http://www.biomedcentral.com/1471-230X/4/23
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was found to associate with serum leptin levels in con-
trols. However, BFM does not associate with serum leptin
levels among cirrhotic patients. Therefore, we conclude
that leptin production may differ among healthy and cir-
rhotic subjects.
In an animal study, it has been shown that chronic etha-
nol consumption leads to increased serum concentrations
of tumor necrosis factor and related cytokines such as lep-
tin by inducing over production of these factors in the
liver and peripheral adipose tissues [21]. Leptin secretion
from adipocytes may be enhanced by cytokines released
as a part of the inflammatory or fibrogenic process. Alter-
Leptin levels in controls and cirrhotic patients by gender and Child-Pugh class Figure 4
Leptin levels in controls and cirrhotic patients by gender and Child-Pugh class. Male patients in the control group had signifi-
cantly lower leptin levels compared to cirrhotic male cases that belongs to B and C classes (p = 0.006, p = 0.008, respectively). 
On the other hand, female gender revealed significant difference only between Child Pugh C class patients and controls (p = 
0.02). In controls and Child Pugh B class patients, females had higher leptin levels than males. *P < 0.02 vs. controls, in the same 
gender. ◆ P < 0.05 vs. different gender in the same group.
Table 2: Linear regression analysis (R2 = 0.326) with serum leptin 
as dependent variable in the cirrhotic group (n = 35).
Independent variables Beta p
Gender (M-F) -0.307 0.065
Age (years) -0.227 0.183
BFM (kg) 0.006 0.974
Viral Etiologic Factor (HBV-HCV) 0.167 0.315
Child-Pugh Classification (A-B-C) 0.435 0.015*
Beta, beta regression coefficient; M, Male; F, Female; BFM, Body fat 
mass; HBV, Hepatitis B Virus; HCV, Hepatitis C Virus; A, Child-Pugh 
Class A; B, Child-Pugh Class B; C, Child-Pugh Class C.Publish with BioMed Central    and   every 
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natively, as suggested, cirrhotic patients may simply
exhibit decreased hepatic clearance of this protein [22].
Conclusion
Serum leptin levels increase in advanced liver disease
independently of gender, body composition and viral eti-
ologic factor in post-hepatitis cirrhosis. The increase is
more abundant among patients that belong to C sub-
group according to the Child- Pugh classification.
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